Top compounds associated with response to LINC00371


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:pluripotin (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA AM-580 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA tamatinib CTRPv2 pan-cancer AAC -0.078 0.03
mRNA I-BET151 CTRPv2 pan-cancer AAC -0.064 0.03
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.071 0.03
mRNA BRD-K27986637 CTRPv2 pan-cancer AAC 0.14 0.04
mRNA momelotinib CTRPv2 pan-cancer AAC -0.067 0.04
mRNA tigecycline CTRPv2 pan-cancer AAC -0.093 0.05
mRNA selumetinib:MK-2206 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.05
mRNA TG-101348 CTRPv2 pan-cancer AAC -0.063 0.05
Download CSV